Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors

Basal Ganglia

Volumn 2, Issue 1, 2012, Pages 5-13

  Zhang, Hui ^a   Sulzer, David ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Autoreceptor; Cyclic voltammetry; Dopamine; Heteroreceptor; Release; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE RECEPTOR; CANNABINOID RECEPTOR; CHOLINERGIC RECEPTOR; DOPAMINE; DOPAMINE AUTORECEPTOR; DOPAMINE HETERORECEPTOR; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ADDICTION; AMPEROMETRY; COGNITION; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; ELECTROCHEMISTRY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEARNING; MOTOR CONTROL; NEUROMODULATION; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

EID: 84858080253     PISSN: 22105336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.baga.2011.11.004     Document Type: Review

References (151)

1. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000, 25:515-532.
2. Wickens J.R., Horvitz J.C., Costa R.M., Killcross S. Dopaminergic mechanisms in actions and habits. J Neurosci 2007, 27:8181-8183.
3. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 2004, 5:483-494.
4. Schmitz Y., Benoit-Marand M., Gonon F., Sulzer D. Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 2003, 87:273-289.
5. Mansvelder H.D., De Rover M., McGehee D.S., Brussaard A.B. Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur J Pharmacol 2003, 480:117-123.
6. B receptor agonists on the mesolimbic dopamine system. Nat Neurosci 2004, 7:153-159.
7. Bonci A., Bernardi G., Grillner P., Mercuri N.B. The dopamine-containing neuron: Maestro or simple musician in the orchestra of addiction?. Trends Pharmacol Sci 2003, 24:172-177.
8. Margolis E.B., Hjelmstad G.O., Bonci A., Fields H.L. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 2003, 23:9981-9986.
9. Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 2011, 69:628-649.
10. Kelly R.S., Wightman R.M. Detection of dopamine overflow and diffusion with voltammetry in slices of rat brain. Brain Res 1987, 423:79-87.
11. Phillips P.E., Stamford J.A. Differential recruitment of N- P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by 'regular' and 'burst' firing. Brain Res 2000, 884:139-146.
12. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 1995, 377:424-428.
13. Zhang W., Yamada M., Gomeza J., Basile A.S., Wess J. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J Neurosci 2002, 22:6347-6352.
14. Cass W.A., Gerhardt G.A. Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 1994, 176:259-263.
15. Rothblat D.S., Schneider J.S. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum. Neurosci Lett 1997, 228:119-122.
16. Sesack S.R., Aoki C., Pickel V.M. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 1994, 14:88-106.
17. Centonze D., Usiello A., Gubellini P., Pisani A., Borrelli E., Bernardi G., et al. Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2l receptors. Neuropsychopharmacology 2002, 27:723-726.
18. Usiello A., Baik J.H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 2000, 408:199-203.
19. Wang Y., Xu R., Sasaoka T., Tonegawa S., Kung M.P., Sankoorikal E.B. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci 2000, 20:8305-8314.
20. 2 autoreceptors. Nat Neurosci 2011, 14:1033-1038.
21. Benoit-Marand M., Borrelli E., Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 2001, 21:9134-9141.
22. L'hirondel M., Cheramy A., Godeheu G., Artaud F., Saiardi A., Borrelli E., et al. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res 1998, 792:253-262.
23. Mercuri N.B., Saiardi A., Bonci A., Picetti R., Calabresi P., Bernardi G., et al. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 1997, 79:323-327.
24. Schmitz Y., Schmauss C., Sulzer D. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 2002, 22:8002-8009.
25. Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J.C., et al. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 2000, 20:8677-8684.
26. Gainetdinov R.R., Grekhova T.V., Sotnikova T.D., Rayevsky K.S. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats. Eur J Pharmacol 1994, 261:327-331.
27. 3) as a target for neuroleptics. Nature 1990, 347:146-151.
28. Tepper J.M., Sun B.C., Martin L.P., Creese I. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci 1997, 17:2519-2530.
29. Zapata A., Witkin J.M., Shippenberg T.S. Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology 2001, 41:351-359.
30. Koeltzow T.E., Xu M., Cooper D.C., Hu X.T., Tonegawa S., Wolf M.E., et al. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 1998, 18:2231-2238.
31. 3 receptors. Neuroscience 2002, 112:39-49.
32. Kuzhikandathil E.V., Oxford G.S. Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells. J Neurosci 1999, 19:1698-1707.
33. Kuzhikandathil E.V., Oxford G.S. Dominant-negative mutants identify a role for GIRK channels in D3 dopamine receptor-mediated regulation of spontaneous secretory activity. J Gen Physiol 2000, 115:697-706.
34. Kuzhikandathil E.V., Yu W., Oxford G.S. Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines. Mol Cell Neurosci 1998, 12:390-402.
35. Tang L., Todd R.D., O'Malley K.L. Dopamine D2 and D3 receptors inhibit dopamine release. J Pharmacol Exp Ther 1994, 270:475-479.
36. Davila V., Yan Z., Craciun L.C., Logothetis D., Sulzer D. D3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neurons. J Neurosci 2003, 23:5693-5697.
37. Svingos A.L., Periasamy S., Pickel V.M. Presynaptic dopamine D(4) receptor localization in the rat nucleus accumbens shell. Synapse 2000, 36:222-232.
38. Starke K., Gother M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 1989, 69:864-989.
39. 3H] dopamine release from rat striatal slices by D-2 dopamine receptors. J Pharmacol Exp Ther 1986, 239:442-453.
40. Cubeddu L.X., Hoffmann I.S. Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors. J Pharmacol Exp Ther 1982, 223:497-501.
41. Cragg S.J., Greenfield S.A. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci 1997, 17:5738-5746.
42. Starke K., Reimann W., Zumstein A., Hertting G. Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol 1978, 305:27-36.
43. Kennedy R.T., Jones S.R., Wightman R.M. Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J Neurochem 1992, 59:449-455.
44. Palij P., Bull D.R., Sheehan M.J., Millar J., Stamford J., Kruk Z.L., et al. Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res 1990, 509:172-174.
45. Mayer A., Limberger N., Starke K. Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors. Naunyn Schmiedebergs Arch Pharmacol 1988, 338:632-643.
46. Phillips P.E., Hancock P.J., Stamford J.A. Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 2002, 44:15-22.
47. B receptors. J Neurophysiol 1995, 74:1137-1148.
48. 2+ channels contrasted with strong regulation of axonal dopamine release. J Neurochem 2006, 96:645-655.
49. + channels. J Neurophysiol 2002, 87:1046-1056.
50. Sulzer D., Joyce M.P., Lin L., Geldwert D., Haber S.N., Hattori T., et al. Dopamine neurons make glutamatergic synapses in vitro. J Neurosci 1998, 18:4588-4602.
51. Cass W.A., Zahniser N.R. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release. J Neurochem 1991, 57:147-152.
52. Fulton S., Thibault D., Mendez J.A., Lahaie N., Tirotta E., Borrelli E., et al. Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow. J Biol Chem 2011, 286:9360-9372.
53. Martel P., Leo D., Fulton S., Berard M., Trudeau L.E. Role of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor function. PLoS One 2011, 6:e20402.
54. i-specific GoLoco motif peptides. J Neurochem 2005, 92:1408-1418.
55. Patel J.C., Witkovsky P., Coetzee W.A., Rice M.E. Subsecond regulation of striatal dopamine release by presynaptic KATP channels. J Neurochem 2011, 118:721-736.
56. Imperato A., Di Chiara G. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci 1985, 5:297-306.
57. Imperato A., Di Chiara G. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 1988, 156:385-393.
58. Westerink B.H., de Vries J.B. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 1989, 99:197-202.
59. May L.J., Wightman R.M. Effects of D-2 antagonists on frequency-dependent stimulated dopamine overflow in nucleus accumbens and caudate-putamen. J Neurochem 1989, 53:898-906.
60. Suaud-Chagny M.F., Ponec J., Gonon F. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry. Neuroscience 1991, 45:641-652.
61. Cheer J.F., Wassum K.M., Heien M.L., Phillips P.E., Wightman R.M. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci 2004, 24:4393-4400.
62. Luscher C., Ungless M.A. The mechanistic classification of addictive drugs. PLoS Med 2006, 3:e437.
63. Araujo D.M., Hilt D.C., Miller P.J., Wen D., Jiao S., Lapchak P.A. Ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways. Neuroscience 1997, 80:9-16.
64. Wonnacott S., Kaiser S., Mogg A., Soliakov L., Jones I.W. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur J Pharmacol 2000, 393:51-58.
65. Svingos A.L., Chavkin C., Colago E.E., Pickel V.M. Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse 2001, 42:185-192.
66. Svingos A.L., Clarke C.L., Pickel V.M. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization. Synapse 1999, 34:1-10.
67. Paquet M., Tremblay M., Soghomonian J.J., Smith Y. AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci 1997, 17:1377-1396.
68. B receptors in the basal ganglia in monkeys. Neuroscience 2000, 95:127-140.
69. Bernard V., Bolam J.P. Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptor. Eur J Neurosci 1998, 10:3721-3736.
70. Anderson B.B., Chen G., Gutman D.A., Ewing A.G. Dopamine levels of two classes of vesicles are differentially depleted by amphetamine. Brain Res 1998, 788:294-301.
71. Schmitz Y., Luccarelli J., Kim M., Wang M., Sulzer D. Glutamate controls growth rate and branching of dopaminergic axons. J Neurosci 2009, 29:11973-11981.
72. 2. J Neurosci 2003, 23:2744-2750.
73. Kulagina N.V., Zigmond M.J., Michael A.C. Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 2001, 102:121-128.
74. Wu Y., Pearl S.M., Zigmond M.J., Michael A.C. Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience 2000, 96:65-72.
75. Iravani M.M., Kruk Z.L. Real-time effects of N-methyl-d-aspartic acid on dopamine release in slices of rat caudate putamen: a study using fast cyclic voltammetry. J Neurochem 1996, 66:1076-1085.
76. Moghaddam B., Gruen R.J., Roth R.H., Bunney B.S., Adams R.N. Effect of l-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res 1990, 518:55-60.
77. Svensson L., Zhang J., Johannessen K., Engel J.A. Effect of local infusion of glutamate analogues into the nucleus accumbens of rats: an electrochemical and behavioural study. Brain Res 1994, 643:155-161.
78. 2 generation in striatal medium spiny neurons but not dopamine axons: one source of a retrograde signal that can inhibit dopamine release. J Neurophysiol 2008, 100:1590-1601.
79. Paquet M., Smith Y. Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J Neurosci 2003, 23:7659-7669.
80. Zhang H., Sulzer D. Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors. J Neurosci 2003, 23:10585-10592.
81. Smolders I., De Klippel N., Sarre S., Ebinger G., Michotte Y. Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. Eur J Pharmacol 1995, 284:83-91.
82. A receptors modulate dopamine release from rat striatal synaptosomes. J Neurochem 1993, 61:1634-1639.
83. De Klippel N., Sarre S., Ebinger G., Michotte Y. Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats. Brain Res 1993, 630:57-64.
84. Kemel M.L., Desban M., Glowinski J., Gauchy C. Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc Natl Acad Sci USA 1989, 86:9006-9010.
85. 3H] dopamine release in vitro by endogenous acetylcholine. Brain Res 1982, 248:61-69.
86. Raiteri M., Leardi R., Marchi M. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther 1984, 228:209-214.
87. 14C] acetylcholine release from rat neostriatal slices: selective antagonism by gallamine but not pirenzepine. Eur J Pharmacol 1986, 128:291-294.
88. Smolders I., Bogaert L., Ebinger G., Michotte Y. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis. J Neurochem 1997, 68:1942-1948.
89. Xu M., Mizobe F., Yamamoto T., Kato T. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res 1989, 495:232-242.
90. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996, 10:69-99.
91. Kudernatsch M., Sutor B. Cholinergic modulation of dopamine overflow in the rat neostriatum: a fast cyclic voltammetric study in vitro. Neurosci Lett 1994, 181:107-112.
92. Dewey S.L., Smith G.S., Logan J., Brodie J.D., Simkowitz P., MacGregor R.R., et al. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci USA 1993, 90:11816-11820.
93. Threlfell S., Clements M.A., Khodai T., Pienaar I.S., Exley R., Wess J., et al. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 2010, 30:3398-3408.
94. Threlfell S., Cragg S.J. Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Front Syst Neurosci 2010, 5:11.
95. Vilaro M.T., Palacios J.M., Mengod G. Localization of M5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 1990, 114:154-159.
96. Weiner D.M., Levey A.I., Brann M.R. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 1990, 87:7050-7054.
97. 3H] dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes. J Neurochem 2007, 102:179-193.
98. Bendor J., Lizardi-Ortiz J.E., Westphalen R.I., Brandstetter M., Hemmings H.C., Sulzer D., et al. AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. EMBO J 2010, 29:2813-2826.
99. Zoli M., Moretti M., Zanardi A., McIntosh J.M., Clementi F., Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 2002, 22:8785-8789.
100. Salminen O., Murphy K.L., McIntosh J.M., Drago J., Marks M.J., Collins A.C., et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 2004, 65:1526-1535.
101. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996, 382:255-257.
102. Cheer J.F., Wassum K.M., Sombers L.A., Heien M.L., Ariansen J.L., Aragona B.J., et al. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 2007, 27:791-795.
103. Zhou F.M., Liang Y., Dani J.A. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 2001, 4:1224-1229.
104. Rice M.E., Cragg S.J. Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 2004, 7:583-584.
105. Zhang H., Sulzer D. Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 2004, 7:581-582.
106. Trovero F., Herve D., Desban M., Glowinski J., Tassin J.P. Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat. Neuroscience 1990, 39:313-321.
107. Schlosser B., Kudernatsch M.B., Sutor B., ten Bruggencate G. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices. Neurosci Lett 1995, 191:126-130.
108. Britt J.P., McGehee D.S. Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens. J Neurosci 2008, 28:1672-1681.
109. Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997, 20:482-487.
110. Jin S., Johansson B., Fredholm B.B. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J Pharmacol Exp Ther 1993, 267:801-808.
111. Quarta D., Borycz J., Solinas M., Patkar K., Hockemeyer J., Ciruela F., et al. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-d-aspartate receptor stimulation. J Neurochem 2004, 91:873-880.
112. 1 receptors self-regulate adenosine release in the striatum: evidence of autoreceptor characteristics. Neuroscience 2010, 171:1006-1015.
113. 2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum. Brain Res 1998, 806:202-209.
114. 1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors. Eur J Neurosci 2007, 26:3421-3428.
115. 1 receptors. Brain Res 1996, 710:79-91.
116. 1 adenosine receptor from rat brain. Mol Pharmacol 1991, 40:1-7.
117. 1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res 1995, 677:193-203.
118. Alexander S.P., Reddington M. The cellular localization of adenosine receptors in rat neostriatum. Neuroscience 1989, 28:645-651.
119. 2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 2001, 431:331-346.
120. 2A receptors in brain: morphological substrates for integration of striatal function. Neurology 2003, 61:S12-S18.
121. Mailleux P., Vanderhaeghen J.J. Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci Lett 1992, 148:173-176.
122. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992, 48:655-668.
123. Matsuda L.A. Molecular aspects of cannabinoid receptors. Crit Rev Neurobiol 1997, 11:143-166.
124. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001, 22:565-572.
125. Szabo B., Muller T., Koch H. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J Neurochem 1999, 73:1084-1089.
126. ATP channels. Neurochem Int 2008, 52:80-88.
127. Fusco F.R., Martorana A., Giampa C., De March Z., Farini D., D'Angelo V., et al. Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study. Synapse 2004, 53:159-167.
128. Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 1993, 327:535-550.
129. Romero J., Garcia-Palomero E., Castro J.G., Garcia-Gil L., Ramos J.A., Fernandez-Ruiz J.J. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res Mol Brain Res 1997, 46:100-108.
130. Julian M.D., Martin A.B., Cuellar B., Rodriguez De Fonseca F., Navarro M., Moratalla R., et al. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience 2003, 119:309-318.
131. Lau T., Schloss P. The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons. Eur J Pharmacol 2008, 578:137-141.
132. Lupica C.R., Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005, 48:1105-1116.
133. Matyas F., Urban G.M., Watanabe M., Mackie K., Zimmer A., Freund T.F., et al. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
134. Riegel A.C., Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 2004, 24:11070-11078.
135. Fernandez-Ruiz J., Gonzales S. Cannabinoid control of motor function at the basal ganglia. Handb Exp Pharmacol 2005, 479-507.
136. O'Neill C., Evers-Donnelly A., Nicholson D., O'Boyle K.M., O'Connor J.J. D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry. J Neurochem 2009, 108:545-551.
137. Fuxe K., Marcellino D., Rivera A., Diaz-Cabiale Z., Filip M., Gago B., et al. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev 2008, 58:415-452.
138. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984, 4:2877-2890.
139. Hyland B.I., Reynolds J.N., Hay J., Perk C.G., Miller R. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 2002, 114:475-492.
140. Schultz W., Apicella P., Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 1993, 13:900-913.
141. Mirenowicz J., Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 1996, 379:449-451.
142. Gonon F. Nonlinear relationship between impulse flow and dopamine release by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 1988, 24:19-28.
143. Zhang T., Zhang L., Liang Y., Siapas A.G., Zhou F.M., Dani J.A. Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. J Neurosci 2009, 29:4035-4043.
144. Grenhoff J., Aston-Jones G., Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 1986, 128:351-358.
145. Ding J., Guzman J.N., Tkatch T., Chen S., Goldberg J.A., Ebert P.J., et al. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci 2006, 9:832-842.
146. Zhang H, Sulzer, D. Possible filtering property of heteroreceptors on nigrostriatal terminals on evoked dopamine release in striatal slice. Gordon Research Conference - Catecholamines 2003.
147. Haber S.N., Fudge J.L., McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 2000, 20:2369-2382.
148. Mani M., Ryan T.A. Live imaging of synaptic vesicle release and retrieval in dopaminergic neurons. Front Neural Circuits 2009, 3:3.
149. Daniel J.A., Galbraith S., Iacovitti L., Abdipranoto A., Vissel B. Functional heterogeneity at dopamine release sites. J Neurosci 2009, 29:14670-14680.
150. Onoa B., Li H., Gagnon-Bartsch J.A., Elias L.A., Edwards R.H. Vesicular monoamine and glutamate transporters select distinct synaptic vesicle recycling pathways. J Neurosci 2010, 30:7917-7927.
151. Gubernator N.G., Zhang H., Staal R.G., Mosharov E.V., Pereira D.B., Yue M., et al. Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals. Science 2009, 324:1441-1444.